Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|October 24, 2022
Laparoscopic treatment for an intrapancreatic accessory spleen: A case reportYihan Zhang, Guodong Shi, Lingdong Meng, et al.
BMC Cancer|December 15, 2023
Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancerXueAng Liu, Jian Shi, Lei Tian, et al.
World Journal of Surgery|July 4, 2018
Afferent Loop Decompression Technique is Associated with a Reduction in Pancreatic Fistula Following PancreaticoduodenectomyJie Yin, Zipeng Lu, Pengfei Wu, et al.
Oncotargets and Therapy|April 18, 2018
Association between WWOX and the risk of malignant tumor, especially among Asians: evidence from a meta-analysisHao Yuan, Yang Wu, Jingjing Zhang, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|April 6, 2016
[Surgical treatment for pancreatic neuroendocrine neoplasmas]Junli Wu, Feng Guo, Jishu Wei, et al.
Oncology Reports|February 27, 2013
miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2Baobao Cai, Yong An, Nan Lv, et al.
BMC Cancer|July 24, 2025
Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world settingQianqian Wang, Nan Lv, Dong Xu, et al.
BMC Surgery|August 18, 2022
Surgical revision for pancreatojejunostomy stricture: a case series of 14 patientsFeng Guo, Shimeng Huang, Tewodross Getu Wolde, et al.
Pancreas|April 17, 2026
Identification of a Novel Chemokine-related Long Non-coding RNA Risk Model Via Comprehensive Prognostic and Immune Analyses in Pancreatic CancerYufeng Zhang, Lingtao Yan, Fengyuan Liu, et al.
Seminars in Oncology|April 18, 2025
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistanceYang Wu, Chun Zhang, Jiacheng Huang, et al.
Pageof 16